A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-T

Cancer immunology research

Volumn 2, Issue 10, 2014, Pages 988-999

  McNeel, Douglas G ^a   Gardner, Thomas A ^a   Higano, Celestia S ^a   Kantoff, Philip W ^a   Small, Eric J ^a   Wener, Mark H ^a   Sims, Robert B ^a   DeVries, Todd ^a   Sheikh, Nadeem A ^a   Dreicer, Robert ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; PLASMA PROTEIN; SIPULEUCEL T; TISSUE EXTRACT;

ADULT; AGED; BLOOD; BONE NEOPLASMS; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EOSINOPHIL; HUMAN; IMMUNOLOGY; KAPLAN MEIER METHOD; LEUKOCYTE COUNT; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PROGNOSIS; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SECONDARY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PROTEINS; BONE NEOPLASMS; CANCER VACCINES; DOUBLE-BLIND METHOD; EOSINOPHILS; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; RETROSPECTIVE STUDIES; TISSUE EXTRACTS; TREATMENT OUTCOME;

EID: 84919654441     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-14-0073     Document Type: Article

References (0)